ArticlePharmaceutics2022

Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4'-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis.

Erica Franceschinis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.